HAND2-AS1 Gene

Name HAND2 antisense RNA 1 (head to head)
Description Predicted to be involved in positive regulation of gene expression. Predicted to act upstream of or within with a positive effect on cardiac right ventricle morphogenesis. Predicted to act upstream of or within transcription elongation by RNA polymerase II. Predicted to be located in chromatin; cytoplasm; and nucleoplasm. [provided by Alliance of Genome Resources, Mar 2025]
Summary
{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\n The long non‐coding RNA "}, {"type": "b", "children": [{"type": "t", "text": "HAND2‑AS1"}]}, {"type": "t", "text": " has emerged as an important regulator in both malignant and non‐malignant diseases. In several human cancers—including endometrioid endometrial, colorectal, esophageal, cervical, non‐small cell lung, breast, gastric, ovarian, glioma, and rectal carcinomas—HAND2‑AS1 expression is markedly downregulated and its lower levels correlate with advanced stage and poor prognosis. In these settings, HAND2‑AS1 acts predominantly as a tumor suppressor by “sponging” oncogenic microRNAs (for example, miR‑1275, miR‑21, miR‑143‑3p, miR‑106a, miR‑300, miR‑146, miR‑769‑5p, and miR‑3118) to restore the expression of key tumor‐suppressive proteins (such as KLF14, TNFAIP3, TIMP3, SOCS5, RUNX2, PHLPP2, and RARB) and by modulating signaling pathways including TGF‑β, PI3K/Akt, NF‑κB, and others."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "1", "end_ref": "11"}]}, {"type": "t", "text": "\n "}]}, {"type": "t", "text": "\n "}, {"type": "p", "children": [{"type": "t", "text": "\n In contrast, one study in liver cancer reported a context‐dependent, oncogenic role for HAND2‑AS1 because it is highly expressed in liver cancer stem cells and facilitates their self‐renewal by recruiting a chromatin‐remodeling complex to activate BMPR1A and downstream bone morphogenetic protein (BMP) signaling."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "12"}]}, {"type": "t", "text": " Notably, additional investigations in hepatocellular carcinoma have described HAND2‑AS1 as a tumor suppressor that, when overexpressed, inhibits cancer cell proliferation and triggers apoptotic pathways via modulation of the miR‑300/SOCS5 axis or by downregulating ROCK2."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "13", "end_ref": "16"}]}, {"type": "t", "text": "\n "}]}, {"type": "t", "text": "\n "}, {"type": "p", "children": [{"type": "t", "text": "\n Beyond cancer, HAND2‑AS1 plays roles in non‐neoplastic conditions. In rheumatoid arthritis, for example, HAND2‑AS1 delivered via mesenchymal stem cell exosomes suppresses synoviocyte proliferation, motility, and inflammation by sponging miR‑143‑3p to upregulate TNFAIP3 and inhibit NF‑κB signaling"}, {"type": "fg", "children": [{"type": "fg_f", "ref": "17"}]}, {"type": "t", "text": "may be cross‐referenced with related studies such as"}, {"type": "fg", "children": [{"type": "fg_f", "ref": "18"}]}, {"type": "t", "text": "for reviews on cancer, although the RA study is distinct). In atherosclerosis, HAND2‑AS1 is decreased in patient plasma and in ox‑LDL–stimulated macrophages, where its overexpression limits foam cell formation by sponging miR‑128, thereby enhancing SIRT1 expression and promoting cholesterol efflux."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "19"}]}, {"type": "t", "text": " Moreover, lower HAND2‑AS1 levels in end‐stage dilated cardiomyopathy are associated with reduced insulin‑like growth factor‑1 levels and poor survival."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "21"}]}, {"type": "t", "text": " In osteoarthritis, HAND2‑AS1 expression declines with aging and disease progression; its overexpression in chondrocytes suppresses IL‑6 production, suggesting a role in modulating inflammatory responses."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "22"}]}, {"type": "t", "text": "\n "}]}, {"type": "t", "text": "\n "}, {"type": "p", "children": [{"type": "t", "text": "\n Finally, genetic deletions encompassing both HAND2 and HAND2‑AS1 have been linked to congenital heart defects, highlighting their contribution to normal cardiac development."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "23"}]}, {"type": "t", "text": " Additional studies in glioma, gastric, and bladder cancers further support its function as a competing endogenous RNA (ceRNA) that modulates key regulators of cell cycle progression (e.g. CDK6), apoptosis, and cell–cell adhesion."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "24", "end_ref": "26"}]}, {"type": "t", "text": " Moreover, analyses in rectal cancer reveal that HAND2‑AS1 is part of an lncRNA–mRNA regulatory network with potential prognostic implications"}, {"type": "fg", "children": [{"type": "fg_f", "ref": "27"}]}, {"type": "t", "text": ", and emerging data indicate that it may also influence cancer stem cell functions."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "28"}]}, {"type": "t", "text": "\n "}]}, {"type": "t", "text": "\n "}, {"type": "p", "children": [{"type": "t", "text": "\n In summary, HAND2‑AS1 displays multifaceted, context‐dependent roles. Depending on the tissue type and molecular milieu, it can function either as an oncogenic factor—promoting cancer stem cell self‐renewal (1)—or as a tumor suppressor that antagonizes malignant progression through ceRNA mechanisms (2–12, 14–16, 22–24, 26). Moreover, its regulatory influence on inflammatory signaling and lipid metabolism underscores its potential as a biomarker and therapeutic target in cardiovascular and degenerative joint diseases."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "21"}, {"type": "fg_f", "ref": "19"}, {"type": "fg_f", "ref": "22"}]}, {"type": "t", "text": " \n Collectively, these studies highlight the critical, yet context‐dependent, contributions of HAND2‑AS1 to human disease pathogenesis."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "12"}, {"type": "fg_f", "ref": "4"}, {"type": "fg_f", "ref": "6"}, {"type": "fg_f", "ref": "9"}, {"type": "fg_f", "ref": "17"}, {"type": "fg_f", "ref": "23"}, {"type": "fg_f", "ref": "20"}, {"type": "fg_f", "ref": "26"}]}, {"type": "t", "text": "\n "}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "Xueying Yang, Chi Chiu Wang, Wayne Yuk Wai Lee, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Long non-coding RNA HAND2-AS1 inhibits invasion and metastasis in endometrioid endometrial carcinoma through inactivating neuromedin U."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Lett (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.canlet.2017.10.028"}], "href": "https://doi.org/10.1016/j.canlet.2017.10.028"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "29107108"}], "href": "https://pubmed.ncbi.nlm.nih.gov/29107108"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "Jianwei Zhou, Jiejun Lin, Hui Zhang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "LncRNA HAND2-AS1 sponging miR-1275 suppresses colorectal cancer progression by upregulating KLF14."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biochem Biophys Res Commun (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.bbrc.2018.07.125"}], "href": "https://doi.org/10.1016/j.bbrc.2018.07.125"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "30078677"}], "href": "https://pubmed.ncbi.nlm.nih.gov/30078677"}]}, {"type": "r", "ref": 3, "children": [{"type": "t", "text": "Yuhua Su, Yajing Liu, Chao Ma, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Mesenchymal stem cell-originated exosomal lncRNA HAND2-AS1 impairs rheumatoid arthritis fibroblast-like synoviocyte activation through miR-143-3p/TNFAIP3/NF-κB pathway."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Orthop Surg Res (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1186/s13018-021-02248-1"}], "href": "https://doi.org/10.1186/s13018-021-02248-1"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "33549125"}], "href": "https://pubmed.ncbi.nlm.nih.gov/33549125"}]}, {"type": "r", "ref": 4, "children": [{"type": "t", "text": "Feng Miao, Ji Chen, Meng Shi, et al. "}, {"type": "b", "children": [{"type": "t", "text": "LncRNA HAND2-AS1 inhibits non-small cell lung cancer migration, invasion and maintains cell stemness through the interactions with TGF-β1."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biosci Rep (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1042/BSR20181525"}], "href": "https://doi.org/10.1042/BSR20181525"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "30509963"}], "href": "https://pubmed.ncbi.nlm.nih.gov/30509963"}]}, {"type": "r", "ref": 5, "children": [{"type": "t", "text": "Yusheng Yan, Shaobin Li, Suihai Wang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Long noncoding RNA HAND2-AS1 inhibits cancer cell proliferation, migration, and invasion in esophagus squamous cell carcinoma by regulating microRNA-21."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Cell Biochem (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/jcb.28233"}], "href": "https://doi.org/10.1002/jcb.28233"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "30520131"}], "href": "https://pubmed.ncbi.nlm.nih.gov/30520131"}]}, {"type": "r", "ref": 6, "children": [{"type": "t", "text": "Junling Gong, Haiying Fan, Jing Deng, et al. "}, {"type": "b", "children": [{"type": "t", "text": "LncRNA HAND2-AS1 represses cervical cancer progression by interaction with transcription factor E2F4 at the promoter of C16orf74."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Cell Mol Med (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1111/jcmm.15117"}], "href": "https://doi.org/10.1111/jcmm.15117"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "32314545"}], "href": "https://pubmed.ncbi.nlm.nih.gov/32314545"}]}, {"type": "r", "ref": 7, "children": [{"type": "t", "text": "Li Xing, Xiaolong Tang, Kaikai Wu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "LncRNA HAND2-AS1 suppressed the growth of triple negative breast cancer via reducing secretion of MSCs derived exosomal miR-106a-5p."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Aging (Albany NY) (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.18632/aging.202148"}], "href": "https://doi.org/10.18632/aging.202148"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "33290256"}], "href": "https://pubmed.ncbi.nlm.nih.gov/33290256"}]}, {"type": "r", "ref": 8, "children": [{"type": "t", "text": "J-R Yang, M-X Shi, Y Zeng "}, {"type": "b", "children": [{"type": "t", "text": "LncRNA HAND2-AS1 inhibits proliferation and promotes apoptosis of chronic myeloid leukemia cells by sponging with micRNA-1275."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Eur Rev Med Pharmacol Sci (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.26355/eurrev_201903_17254"}], "href": "https://doi.org/10.26355/eurrev_201903_17254"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "30915755"}], "href": "https://pubmed.ncbi.nlm.nih.gov/30915755"}]}, {"type": "r", "ref": 9, "children": [{"type": "t", "text": "Yan Gao, Ting Zou, Wentong Liang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Long non-coding RNA HAND2-AS1 delays cervical cancer progression via its regulation on the microRNA-21-5p/TIMP3/VEGFA axis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Gene Ther (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/s41417-020-00243-y"}], "href": "https://doi.org/10.1038/s41417-020-00243-y"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "33139818"}], "href": "https://pubmed.ncbi.nlm.nih.gov/33139818"}]}, {"type": "r", "ref": 10, "children": [{"type": "t", "text": "Yumei Wang, Xinglong Cai "}, {"type": "b", "children": [{"type": "t", "text": "Long noncoding RNA HAND2-AS1 restrains proliferation and metastasis of breast cancer cells through sponging miR-1275 and promoting SOX7."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Biomark (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.3233/CBM-190530"}], "href": "https://doi.org/10.3233/CBM-190530"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31683462"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31683462"}]}, {"type": "r", "ref": 11, "children": [{"type": "t", "text": "Li Zhang, Chengyan Jin, Guiyun Yang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "LncRNA WTAPP1 promotes cancer cell invasion and migration in NSCLC by downregulating lncRNA HAND2-AS1."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "BMC Pulm Med (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1186/s12890-020-01180-0"}], "href": "https://doi.org/10.1186/s12890-020-01180-0"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "32473628"}], "href": "https://pubmed.ncbi.nlm.nih.gov/32473628"}]}, {"type": "r", "ref": 12, "children": [{"type": "t", "text": "Yanying Wang, Pingping Zhu, Jianjun Luo, et al. "}, {"type": "b", "children": [{"type": "t", "text": "LncRNA HAND2-AS1 promotes liver cancer stem cell self-renewal via BMP signaling."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "EMBO J (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.15252/embj.2018101110"}], "href": "https://doi.org/10.15252/embj.2018101110"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31334575"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31334575"}]}, {"type": "r", "ref": 13, "children": [{"type": "t", "text": "Hua-Qiang Bi, Zhong-Hui Li, Hui Zhang "}, {"type": "b", "children": [{"type": "t", "text": "Long noncoding RNA HAND2-AS1 reduced the viability of hepatocellular carcinoma via targeting microRNA-300/SOCS5 axis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Hepatobiliary Pancreat Dis Int (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.hbpd.2020.02.011"}], "href": "https://doi.org/10.1016/j.hbpd.2020.02.011"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "32224127"}], "href": "https://pubmed.ncbi.nlm.nih.gov/32224127"}]}, {"type": "r", "ref": 14, "children": [{"type": "t", "text": "Ting Gao, Xiaoqiang Dai, Yindi Jiang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "LncRNA HAND2-AS1 inhibits proliferation and promotes apoptosis of non-small cell lung cancer cells by inactivating PI3K/Akt pathway."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biosci Rep (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1042/BSR20201870"}], "href": "https://doi.org/10.1042/BSR20201870"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "32975291"}], "href": "https://pubmed.ncbi.nlm.nih.gov/32975291"}]}, {"type": "r", "ref": 15, "children": [{"type": "t", "text": "Guolei Dong, Xiaorui Wang, Yan Jia, et al. "}, {"type": "b", "children": [{"type": "t", "text": "HAND2-AS1 Works as a ceRNA of miR-3118 to Suppress Proliferation and Migration in Breast Cancer by Upregulating PHLPP2."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biomed Res Int (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1155/2020/8124570"}], "href": "https://doi.org/10.1155/2020/8124570"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "33015182"}], "href": "https://pubmed.ncbi.nlm.nih.gov/33015182"}]}, {"type": "r", "ref": 16, "children": [{"type": "t", "text": "Gui-Ying Jing, Xuan-Zhen Zheng, Xiao-Xia Ji "}, {"type": "b", "children": [{"type": "t", "text": "lncRNA HAND2-AS1 overexpression inhibits cancer cell proliferation in hepatocellular carcinoma by downregulating RUNX2 expression."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Clin Lab Anal (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/jcla.23717"}], "href": "https://doi.org/10.1002/jcla.23717"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "33566427"}], "href": "https://pubmed.ncbi.nlm.nih.gov/33566427"}]}, {"type": "r", "ref": 17, "children": [{"type": "t", "text": "Lijun Li, Li Li, Lian Hu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Long non‑coding RNA HAND2‑AS1/miR‑106a/PTEN axis re‑sensitizes cisplatin‑resistant ovarian cells to cisplatin treatment."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Med Rep (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.3892/mmr.2021.12402"}], "href": "https://doi.org/10.3892/mmr.2021.12402"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "34476500"}], "href": "https://pubmed.ncbi.nlm.nih.gov/34476500"}]}, {"type": "r", "ref": 18, "children": [{"type": "t", "text": "Xinyu Gu, Qiuxian Zheng, Qingfei Chu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "HAND2-AS1: A functional cancer-related long non-coding RNA."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biomed Pharmacother (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.biopha.2021.111317"}], "href": "https://doi.org/10.1016/j.biopha.2021.111317"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "33556872"}], "href": "https://pubmed.ncbi.nlm.nih.gov/33556872"}]}, {"type": "r", "ref": 19, "children": [{"type": "t", "text": "Lingyun Ma, Shigui He, Helan Li, et al. "}, {"type": "b", "children": [{"type": "t", "text": "HAND2-AS1 targeting miR-1208/SIRT1 axis alleviates foam cell formation in atherosclerosis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Int J Cardiol (2022)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.ijcard.2021.11.019"}], "href": "https://doi.org/10.1016/j.ijcard.2021.11.019"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "34780888"}], "href": "https://pubmed.ncbi.nlm.nih.gov/34780888"}]}, {"type": "r", "ref": 20, "children": [{"type": "t", "text": "Danyu Li, Yunci Ma, Weiqian Deng, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Construction and Analysis of lncRNA-Associated ceRNA Network in Atherosclerotic Plaque Formation."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biomed Res Int (2022)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1155/2022/4895611"}], "href": "https://doi.org/10.1155/2022/4895611"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "35463977"}], "href": "https://pubmed.ncbi.nlm.nih.gov/35463977"}]}, {"type": "r", "ref": 21, "children": [{"type": "t", "text": "Xianlu Cheng, Hong Jiang "}, {"type": "b", "children": [{"type": "t", "text": "Long non-coding RNA HAND2-AS1 downregulation predicts poor survival of patients with end-stage dilated cardiomyopathy."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Int Med Res (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1177/0300060519849295"}], "href": "https://doi.org/10.1177/0300060519849295"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31248315"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31248315"}]}, {"type": "r", "ref": 22, "children": [{"type": "t", "text": "Zhenxing Si, Shifeng Zhou, Zilong Shen, et al. "}, {"type": "b", "children": [{"type": "t", "text": "lncRNA HAND2-AS1 is downregulated in osteoarthritis and regulates IL-6 expression in chondrocytes."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Orthop Surg Res (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1186/s13018-021-02216-9"}], "href": "https://doi.org/10.1186/s13018-021-02216-9"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "33468183"}], "href": "https://pubmed.ncbi.nlm.nih.gov/33468183"}]}, {"type": "r", "ref": 23, "children": [{"type": "t", "text": "Ana S A Cohen, Christopher Simotas, Bryn D Webb, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Haploinsufficiency of the basic helix-loop-helix transcription factor HAND2 causes congenital heart defects."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Am J Med Genet A (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/ajmg.a.61537"}], "href": "https://doi.org/10.1002/ajmg.a.61537"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "32134193"}], "href": "https://pubmed.ncbi.nlm.nih.gov/32134193"}]}, {"type": "r", "ref": 24, "children": [{"type": "t", "text": "Songlin Liu, Yifeng Li "}, {"type": "b", "children": [{"type": "t", "text": "LncRNA HAND2-AS1 attenuates glioma cell proliferation, invasion and migration by targeting CDK6."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Neurol Res (2022)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1080/01616412.2022.2035620"}], "href": "https://doi.org/10.1080/01616412.2022.2035620"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "35548927"}], "href": "https://pubmed.ncbi.nlm.nih.gov/35548927"}]}, {"type": "r", "ref": 25, "children": [{"type": "t", "text": "Lan Yu, Wei Luan, Zongqi Feng, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Long non-coding RNA HAND2-AS1 inhibits gastric cancer progression by suppressing TCEAL7 expression via targeting miR-769-5p."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Dig Liver Dis (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.dld.2020.08.045"}], "href": "https://doi.org/10.1016/j.dld.2020.08.045"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "32952069"}], "href": "https://pubmed.ncbi.nlm.nih.gov/32952069"}]}, {"type": "r", "ref": 26, "children": [{"type": "t", "text": "Liping Shan, Wei Liu, Yunhong Zhan "}, {"type": "b", "children": [{"type": "t", "text": "LncRNA HAND2-AS1 exerts anti-oncogenic effects on bladder cancer via restoration of RARB as a sponge of microRNA-146."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Cell Int (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1186/s12935-021-02063-y"}], "href": "https://doi.org/10.1186/s12935-021-02063-y"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "34238300"}], "href": "https://pubmed.ncbi.nlm.nih.gov/34238300"}]}, {"type": "r", "ref": 27, "children": [{"type": "t", "text": "Guoying Cai, Meifei Sun, Xinrong Li, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Construction and characterization of rectal cancer-related lncRNA-mRNA ceRNA network reveals prognostic biomarkers in rectal cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "IET Syst Biol (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1049/syb2.12035"}], "href": "https://doi.org/10.1049/syb2.12035"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "34613665"}], "href": "https://pubmed.ncbi.nlm.nih.gov/34613665"}]}, {"type": "r", "ref": 28, "children": [{"type": "t", "text": "Soudeh Ghafouri-Fard, Mohammadreza Hajiesmaeili, Hamed Shoorei, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The Impact of lncRNAs and miRNAs in Regulation of Function of Cancer Stem Cells and Progression of Cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Front Cell Dev Biol (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.3389/fcell.2021.696820"}], "href": "https://doi.org/10.3389/fcell.2021.696820"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "34368145"}], "href": "https://pubmed.ncbi.nlm.nih.gov/34368145"}]}]}]}
Synonyms UPH, DEIN, NBLA00301
NCBI Gene ID 79804
API
Download Associations
Predicted Functions View HAND2-AS1's ARCHS4 Predicted Functions.
Co-expressed Genes View HAND2-AS1's ARCHS4 Predicted Functions.
Expression in Tissues and Cell Lines View HAND2-AS1's ARCHS4 Predicted Functions.

Functional Associations

HAND2-AS1 has 1,773 functional associations with biological entities spanning 6 categories (molecular profile, chemical, disease, phenotype or trait, functional term, phrase or reference, cell line, cell type or tissue, gene, protein or microRNA) extracted from 31 datasets.

Click the + buttons to view associations for HAND2-AS1 from the datasets below.

If available, associations are ranked by standardized value

Dataset Summary
Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by Microarray tissue samples with high or low expression of HAND2-AS1 gene relative to other tissue samples from the Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by Microarray dataset.
BioGPS Cell Line Gene Expression Profiles cell lines with high or low expression of HAND2-AS1 gene relative to other cell lines from the BioGPS Cell Line Gene Expression Profiles dataset.
BioGPS Human Cell Type and Tissue Gene Expression Profiles cell types and tissues with high or low expression of HAND2-AS1 gene relative to other cell types and tissues from the BioGPS Human Cell Type and Tissue Gene Expression Profiles dataset.
CCLE Cell Line Gene CNV Profiles cell lines with high or low copy number of HAND2-AS1 gene relative to other cell lines from the CCLE Cell Line Gene CNV Profiles dataset.
CCLE Cell Line Gene Expression Profiles cell lines with high or low expression of HAND2-AS1 gene relative to other cell lines from the CCLE Cell Line Gene Expression Profiles dataset.
ChEA Transcription Factor Binding Site Profiles transcription factor binding site profiles with transcription factor binding evidence at the promoter of HAND2-AS1 gene from the CHEA Transcription Factor Binding Site Profiles dataset.
ChEA Transcription Factor Targets transcription factors binding the promoter of HAND2-AS1 gene in low- or high-throughput transcription factor functional studies from the CHEA Transcription Factor Targets dataset.
CMAP Signatures of Differentially Expressed Genes for Small Molecules small molecule perturbations changing expression of HAND2-AS1 gene from the CMAP Signatures of Differentially Expressed Genes for Small Molecules dataset.
CTD Gene-Disease Associations diseases associated with HAND2-AS1 gene/protein from the curated CTD Gene-Disease Associations dataset.
ENCODE Histone Modification Site Profiles histone modification site profiles with high histone modification abundance at HAND2-AS1 gene from the ENCODE Histone Modification Site Profiles dataset.
ENCODE Transcription Factor Binding Site Profiles transcription factor binding site profiles with transcription factor binding evidence at the promoter of HAND2-AS1 gene from the ENCODE Transcription Factor Binding Site Profiles dataset.
ENCODE Transcription Factor Targets transcription factors binding the promoter of HAND2-AS1 gene in ChIP-seq datasets from the ENCODE Transcription Factor Targets dataset.
GDSC Cell Line Gene Expression Profiles cell lines with high or low expression of HAND2-AS1 gene relative to other cell lines from the GDSC Cell Line Gene Expression Profiles dataset.
GeneRIF Biological Term Annotations biological terms co-occuring with HAND2-AS1 gene in literature-supported statements describing functions of genes from the GeneRIF Biological Term Annotations dataset.
GEO Signatures of Differentially Expressed Genes for Gene Perturbations gene perturbations changing expression of HAND2-AS1 gene from the GEO Signatures of Differentially Expressed Genes for Gene Perturbations dataset.
GEO Signatures of Differentially Expressed Genes for Kinase Perturbations kinase perturbations changing expression of HAND2-AS1 gene from the GEO Signatures of Differentially Expressed Genes for Kinase Perturbations dataset.
GEO Signatures of Differentially Expressed Genes for Small Molecules small molecule perturbations changing expression of HAND2-AS1 gene from the GEO Signatures of Differentially Expressed Genes for Small Molecules dataset.
GEO Signatures of Differentially Expressed Genes for Transcription Factor Perturbations transcription factor perturbations changing expression of HAND2-AS1 gene from the GEO Signatures of Differentially Expressed Genes for Transcription Factor Perturbations dataset.
GTEx Tissue Gene Expression Profiles tissues with high or low expression of HAND2-AS1 gene relative to other tissues from the GTEx Tissue Gene Expression Profiles dataset.
GTEx Tissue Sample Gene Expression Profiles tissue samples with high or low expression of HAND2-AS1 gene relative to other tissue samples from the GTEx Tissue Sample Gene Expression Profiles dataset.
GTEx Tissue-Specific Aging Signatures tissue samples with high or low expression of HAND2-AS1 gene relative to other tissue samples from the GTEx Tissue-Specific Aging Signatures dataset.
GWASdb SNP-Disease Associations diseases associated with HAND2-AS1 gene in GWAS and other genetic association datasets from the GWASdb SNP-Disease Associations dataset.
GWASdb SNP-Phenotype Associations phenotypes associated with HAND2-AS1 gene in GWAS datasets from the GWASdb SNP-Phenotype Associations dataset.
JASPAR Predicted Transcription Factor Targets transcription factors regulating expression of HAND2-AS1 gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Transcription Factor Targets dataset.
Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles cell lines with high or low copy number of HAND2-AS1 gene relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles dataset.
LINCS L1000 CMAP Chemical Perturbation Consensus Signatures small molecule perturbations changing expression of HAND2-AS1 gene from the LINCS L1000 CMAP Chemical Perturbations Consensus Signatures dataset.
LINCS L1000 CMAP CRISPR Knockout Consensus Signatures gene perturbations changing expression of HAND2-AS1 gene from the LINCS L1000 CMAP CRISPR Knockout Consensus Signatures dataset.
LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules small molecule perturbations changing expression of HAND2-AS1 gene from the LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules dataset.
LOCATE Predicted Protein Localization Annotations cellular components predicted to contain HAND2-AS1 protein from the LOCATE Predicted Protein Localization Annotations dataset.
Roadmap Epigenomics Histone Modification Site Profiles histone modification site profiles with high histone modification abundance at HAND2-AS1 gene from the Roadmap Epigenomics Histone Modification Site Profiles dataset.
TCGA Signatures of Differentially Expressed Genes for Tumors tissue samples with high or low expression of HAND2-AS1 gene relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset.